Iontophoresis for medical indications.
D000279:Administration, Cutaneous; D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000779:Anesthetics, Local / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D054598:Blue Cross Blue Shield Insurance Plans; D062109:Dermatologic Surgical Procedures; D018795:Device Approval; D019317:Evidence-Based Medicine; D006801:Humans; D006945:Hyperhidrosis / Q000628:therapy; D019458:Insurance Coverage; D007478:Iontophoresis / Q000379:methods*; D009140:Musculoskeletal Diseases / Q000188:drug therapy; D017063:Outcome Assessment, Health Care; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration
D000305:Adrenal Cortex Hormones; D000779:Anesthetics, Local; D000893:Anti-Inflammatory Agents